Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-02

Clinical Trial Update: Oral Ketamine Administration in Patients With Peripheral Neuropathic Pain [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating oral ketamine for peripheral neuropathic pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Neuropathic Pain | Phase 2 | Status: COMPLETED